CVS HEALTH CORP. DL-,01/ US1266501006 /
21/05/2024 09:56:43 | Chg. -0.260 | Volume | Bid21/05/2024 | Demandez à21/05/2024 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
52.810EUR | -0.49% | - Chiffrre d'affaires: - |
52.810Bid taille: 200 | 52.940Ask la taille: 200 | 66.37 Mrd.EUR | - | - |
GlobeNewswire
10:00
Heineken Silver is on a mission to end bitterness, starting with one of the biggest love-hate relati...
GlobeNewswire
10:00
UP Fintech Holding Limited to Report First Quarter 2024 Financial Results on June 5, 2024
GlobeNewswire
10:00
LUNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Luna Innovations Incorporated ...
GlobeNewswire
10:00
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
10:00
PERI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Perion Network Ltd. Investors ...
GlobeNewswire
10:00
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with ...
GlobeNewswire
10:00
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Inves...
GlobeNewswire
10:00
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire
09:30
NewHydrogen CEO Steve Hill Discusses Development of Standalone Hydrogen Evolution System with SDSU E...
GlobeNewswire
09:15
HEALWELL AI’s Pentavere Partners with Sunnybrook and Successfully Demonstrates its AI Powered Clinic...
Newsfile Corp
09:05
Great Eagle Gold Corp. Now Trading on U.S. OTC Market and Announces Timely Private Placement Opportu...
GlobeNewswire
09:00
NEXEN TIRE’s official partner of Manchester City crowned 2023/24 Premier League Champions
GlobeNewswire
09:00
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Mile...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page